Page last updated: 2024-09-04

cyc 202 and Hyperplasia

cyc 202 has been researched along with Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, H; He, M; Hou, JM; Ji, ES; Li, AY; Li, YF; Liu, Y; Song, JN; Sun, JH; Wang, C; Wang, H; Zhao, JS	1

Other Studies

1 other study(ies) available for cyc 202 and Hyperplasia

Article	Year
Roscovitine attenuates intimal hyperplasia via inhibiting NF-κB and STAT3 activation induced by TNF-α in vascular smooth muscle cells. Biochemical pharmacology, 2017, 08-01, Volume: 137 Topics: Animals; Carotid Arteries; Cells, Cultured; Dose-Response Relationship, Drug; Hyperplasia; Male; Muscle, Smooth, Vascular; NF-kappa B; Organ Culture Techniques; Purines; Random Allocation; Rats; Rats, Sprague-Dawley; Roscovitine; Tumor Necrosis Factor-alpha; Tunica Intima	2017

Article

Year

Roscovitine attenuates intimal hyperplasia via inhibiting NF-κB and STAT3 activation induced by TNF-α in vascular smooth muscle cells.

Biochemical pharmacology, 2017, 08-01, Volume: 137

Topics: Animals; Carotid Arteries; Cells, Cultured; Dose-Response Relationship, Drug; Hyperplasia; Male; Muscle, Smooth, Vascular; NF-kappa B; Organ Culture Techniques; Purines; Random Allocation; Rats; Rats, Sprague-Dawley; Roscovitine; Tumor Necrosis Factor-alpha; Tunica Intima

2017